AVAH

Aveanna Healthcare Holdings Inc. [AVAH] Stock Forecast

Q: What is Aveanna Healthcare Holdings Inc. stock symbol ?

Aveanna Healthcare Holdings Inc. is a US stock, located in Atlanta of Ga and trading under the symbol AVAH

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

AVAH Stock Summary

Earnings have grown 6.02% per last year.

Earnings are expected to fall -100% next year

Profit margins (-0.19%) are lower than the previous year (-0.07%)

AVAH has less than 1 year of cash runway

Top 10 Correlated ETFs

AVAH

Top 10 Correlated Stocks

AVAH

In the News

AVAH Financial details

Company Rating

Neutral

Market Cap

450.17M

Income

-134.52M

Revenue

1.9B

Book val./share

-0.68

Cash/share

0.23

Dividend

Dividend %

Employees

33.5K

Optionable

Shortable

Yes

Earnings

09 May 2024

P/E

-1.37

Forward P/E

PEG

0.17

P/S

0.26

P/B

-4.58

P/C

9.78

P/FCF

-21.45

Quick Ratio

0.81

Current Ratio

0.87

Debt / Equity

-11.26

LT Debt / Equity

-9.85

EPS (TTM)

-0.7

EPS next Y

EPS next Q

EPS this Y

-80.11%

EPS next Y

EPS next 5Y

EPS last 5Y

11.61%

Revenue last 5Y

6.49%

Revenue Q/Q

0.17%

EPS Q/Q

-75.93%

SMA20

SMA50

SMA100

Inst Own

39.69%

Inst Trans

0.44%

ROA

-21%

ROE

949%

ROC

-0.02%

Gross Margin

31%

Oper. Margin

-1%

Profit Margin

-19%

Payout

Shs Outstand

Shs Float

Target Price

52W Range

0.85-3.0

52W High

52W Low

RSI

Rel Volume

0.38

Avg Volume

92.74K

Volume

35.56K

Perf Week

-6.25%

Perf Month

1.81%

Perf Quarter

89.08%

Perf Half Y

74.42%

Beta

2.036

Volatility

0.06%, 0.1%

Prev Close

1.35%

Price

2.25

Change

-1.75%

AVAH Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-12-30

Metric	2019-12-31	2020-12-31	2022-01-01	2022-12-31	2023-12-30
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	7.45	8.04	9.09	9.63	9.98
Net income per share	-0.41	-0.31	-0.63	-3.57	-0.71
Operating cash flow per share	-0.05	0.63	-0.06	-0.26	0.12
Free cash flow per share	-0.14	0.55	-0.15	-0.33	0.09
Cash per share	0.02	0.74	0.17	0.1	0.23
Book value per share	1.46	1.44	3.45	-0.02	-0.68
Tangible book value per share	-5.43	-6.04	-7.04	-6.79	-6.72
Share holders equity per share	1.46	1.44	3.45	-0.02	-0.68
Interest debt per share	6.3	7.05	7.4	7.84	8.49
Market cap	2.23B	2.23B	1.37B	144.73M	509.08M
Enterprise value	3.31B	3.32B	2.63B	1.48B	1.96B
P/E ratio	-29.15	-39.1	-11.68	-0.22	-3.78
Price to sales ratio	1.61	1.49	0.81	0.08	0.27
POCF ratio	-256	19.13	-120.44	-2.99	22.45
PFCF ratio	-88	22	-50.07	-2.4	30.75
P/B Ratio	8.23	8.35	2.14	-34.67	-3.93
PTB ratio	8.23	8.35	2.14	-34.67	-3.93
EV to sales	2.39	2.22	1.57	0.83	1.04
Enterprise value over EBITDA	46.06	29.61	20.06	22.74	13.6
EV to operating cash flow	-379.52	28.48	-232.16	-30.6	86.64
EV to free cash flow	-130.45	32.77	-96.52	-24.51	118.65
Earnings yield	-0.03	-0.03	-0.09	-4.57	-0.26
Free cash flow yield	-0.01	0.05	-0.02	-0.42	0.03
Debt to equity	3.98	4.6	2.04	-324.63	-11.26
Debt to assets	0.68	0.67	0.56	0.79	0.89
Net debt to EBITDA	14.99	9.73	9.65	20.52	10.07
Current ratio	1.11	1.31	0.81	0.83	0.89
Interest coverage	0.42	0.99	1.39	0.26	0.75
Income quality	0.11	-2.04	0.1	0.07	-0.17
Dividend Yield	0	0	0	0	0
Payout ratio	0	0	0	0	0
Sales general and administrative to revenue	0.25	0.24	0.25	0.27	0.25
Research and developement to revenue	0	0	0	0	0
Intangibles to total assets	0.81	0.75	0.83	0.73	0.7
Capex to operating cash flow	1.91	-0.13	1.41	0.25	-0.27
Capex to revenue	-0.01	-0.01	-0.01	-0.01	0
Capex to depreciation	-0.62	-0.5	-0.45	-0.31	-0.2
Stock based compensation to revenue	0	0	0.01	0.01	0.01
Graham number	3.67	3.15	7.02	1.34	3.3
ROIC	0.03	0.06	0.05	0.02	0.08
Return on tangible assets	-0.26	-0.13	-0.3	-1.45	-0.28
Graham Net	-6.33	-6.98	-8.06	-8.19	-8.09
Working capital	17.8M	80.23M	-65.62M	-56.75M	-39.87M
Tangible asset value	-1.01B	-1.12B	-1.3B	-1.26B	-1.28B
Net current asset value	-1.12B	-1.24B	-1.42B	-1.45B	-1.45B
Invested capital	3.98	4.6	2.04	-324.63	-11.26
Average receivables	0	172.59M	203.08M	225.46M	235.72M
Average payables	0	61.54M	54.65M	48.62M	37.38M
Average inventory	0	10.62M	12.66M	14.66M	7.54M
Days sales outstanding	43.33	44.16	48.99	46.07	47.34
Days payables outstanding	25.13	19.88	16.91	13.19	8.37
Days of inventory on hand	3.84	3.89	4.57	4.46	0
Receivables turnover	8.42	8.27	7.45	7.92	7.71
Payables turnover	14.53	18.36	21.59	27.66	43.6
Inventory turnover	94.94	93.92	79.83	81.81	0
ROE	-0.28	-0.21	-0.18	158.57	1.04
Capex per share	-0.09	-0.08	-0.09	-0.06	-0.03

Quarterly Fundamentals Overview

Last date of statement is 2023-12-30 for Q4

Metric	2022-12-31	2023-04-01	2023-07-01	2023-09-30	2023-12-30
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	2.42	2.47	2.5	2.53	2.51
Net income per share	-1.28	-0.17	0.14	-0.54	-0.13
Operating cash flow per share	-0.22	0.04	-0.06	0.15	-0.02
Free cash flow per share	-0.23	0.03	-0.06	0.15	-0.02
Cash per share	0.1	0.18	0.15	0.26	0.23
Book value per share	-0.02	-0.18	-0.02	-0.55	-0.68
Tangible book value per share	-6.77	-6.83	-6.67	-6.63	-6.68
Share holders equity per share	-0.02	-0.18	-0.02	-0.55	-0.68
Interest debt per share	7.45	7.31	7.31	7.31	7.85
Market cap	145.21M	196.62M	319.53M	225.08M	511.69M
Enterprise value	1.48B	1.51B	1.64B	1.52B	1.97B
P/E ratio	-0.15	-1.54	3.12	-0.55	-4.97
Price to sales ratio	0.32	0.42	0.68	0.47	1.07
POCF ratio	-3.61	26.23	-30.38	7.84	-170.28
PFCF ratio	-3.34	36.59	-27.04	8.16	-111.89
P/B Ratio	-34.78	-5.83	-69.43	-2.17	-3.95
PTB ratio	-34.78	-5.83	-69.43	-2.17	-3.95
EV to sales	3.28	3.24	3.47	3.18	4.11
Enterprise value over EBITDA	195.89	61.97	24.71	41.57	49.86
EV to operating cash flow	-36.82	201.53	-155.59	52.97	-654.56
EV to free cash flow	-34.09	281.12	-138.49	55.13	-430.12
Earnings yield	-1.64	-0.16	0.08	-0.45	-0.05
Free cash flow yield	-0.3	0.03	-0.04	0.12	-0.01
Debt to equity	-324.63	-39.97	-292.26	-12.97	-11.26
Debt to assets	0.79	0.78	0.77	0.81	0.89
Net debt to EBITDA	176.69	53.9	19.88	35.42	36.89
Current ratio	0.83	0.82	0.85	0.87	0.89
Interest coverage	-0.06	0.51	0.99	-1.93	0.81
Income quality	0.17	-0.23	-0.41	-0.28	0.12
Dividend Yield	0	0	0	0	0
Payout ratio	0	0	0	0	0
Sales general and administrative to revenue	0.25	0.13	0.19	0.25	0.22
Research and developement to revenue	0	0	0	0	0
Intangibles to total assets	0.73	0.73	0.72	0.69	0.7
Capex to operating cash flow	0.08	-0.28	0.12	-0.04	0.52
Capex to revenue	-0.01	0	0	0	0
Capex to depreciation	-0.34	-0.26	-0.17	-0.15	-0.22
Stock based compensation to revenue	0	0.01	0.01	0.01	0.01
Graham number	0.8	0.82	0.27	2.58	1.43
ROIC	0	0.01	0.03	-0.06	0.02
Return on tangible assets	-0.52	-0.07	0.05	-0.2	-0.05
Graham Net	-8.16	-8.13	-8.08	-8.03	-8.05
Working capital	-56.75M	-67.25M	-54.33M	-46.06M	-39.87M
Tangible asset value	-1.26B	-1.29B	-1.26B	-1.25B	-1.28B
Net current asset value	-1.45B	-1.46B	-1.44B	-1.44B	-1.45B
Invested capital	-324.63	-39.97	-292.26	-12.97	-11.26
Average receivables	225.83M	236.13M	245.33M	245.21M	246.1M
Average payables	46.79M	43.6M	40.51M	37.48M	33.33M
Average inventory	13.85M	15.84M	16.42M	14.3M	6.18M
Days sales outstanding	45.01	47.59	46.53	46.39	46.2
Days payables outstanding	12.46	11.9	10.92	9.94	8.13
Days of inventory on hand	4.21	4.64	4.62	3.36	0
Receivables turnover	2	1.89	1.93	1.94	1.95
Payables turnover	7.22	7.56	8.24	9.05	11.07
Inventory turnover	21.36	19.41	19.49	26.78	0
ROE	56.95	0.95	-5.56	0.99	0.2
Capex per share	-0.02	-0.01	-0.01	-0.01	-0.01

AVAH Frequently Asked Questions

What is Aveanna Healthcare Holdings Inc. stock symbol ?

Aveanna Healthcare Holdings Inc. is a US stock , located in Atlanta of Ga and trading under the symbol AVAH

What is Aveanna Healthcare Holdings Inc. stock quote today ?

Aveanna Healthcare Holdings Inc. stock price is $2.25 today.

Is Aveanna Healthcare Holdings Inc. stock public?

Yes, Aveanna Healthcare Holdings Inc. is a publicly traded company.

Something similar

Top by Market Cap

Top Correlated ETFs

Company Profile

Volume Average 92.74K
Market Capitalization 450.17M
Employee 33.5K
CEO Mr. Jeffrey S. Shaner
Headquarters Atlanta,GA,US
IPO Date 2021-04-28
Website https://www.aveanna.com

Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides private duty nursing (PDN), adult home health and hospice, home-based pediatric therapy, and enteral nutrition services in the United States. Its patient- centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers PDN services, which include in-home skilled nursing services to medically fragile children; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and employer of record support and personal care services, as well as in-clinic and home-based pediatric therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.